Device and methods for treating paranasal sinus conditions
First Claim
Patent Images
1. A device for treating a paranasal sinus condition comprising a cavity member, a nasal portion, and one or more active agent for sustained release.
2 Assignments
0 Petitions
Accused Products
Abstract
Described here are paranasal sinus devices for treating paranasal sinus conditions. The devices include a cavity member, ostial member, and nasal portion. One or more of the cavity member, ostial member, and nasal portion may deliver an active agent for sustained release to treat the paranasal sinus condition. Exemplary paranasal sinus conditions are sinus inflammation due to functional endoscopic sinus surgery (FESS) and rhinosinusitis.
388 Citations
114 Claims
- 1. A device for treating a paranasal sinus condition comprising a cavity member, a nasal portion, and one or more active agent for sustained release.
-
53. A device for treating a paranasal sinus condition comprising:
-
a) an ostial member having a proximal end and a distal end;
b) a cavity member attached to the ostial member distal end;
c) optionally, a nasal portion attached to the ostial member proximal end; and
d) an active agent for sustained release, wherein the cavity member, the ostial member, and optional nasal portion comprise a biocompatible material and the active agent is released from the cavity member, the ostial member, the nasal portion, or any combination thereof, to treat the paranasal sinus condition. - View Dependent Claims (54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91)
-
-
92. A system for treating a paranasal sinus condition comprising:
-
a) a sinus inserter comprising a conduit having a lumen and a distal portion;
b) a paranasal sinus device within the lumen or releasably secured to the distal portion of the sinus inserter, the paranasal sinus device comprising a cavity member, a ostial member, and optionally a nasal portion, wherein the cavity member has a first collapsed configuration that permits the device to pass through a sinus ostium or surgically created fenestration and a second expanded configuration after placement into a sinus cavity. - View Dependent Claims (93, 94, 95, 96, 97)
-
-
98. A method for treating a paranasal sinus condition comprising:
-
a) providing a paranasal sinus device comprising a cavity member, a ostial member, and optionally a nasal portion within or on a sinus inserter;
b) accessing a paranasal sinus with the sinus inserter;
c) deploying the paranasal sinus device so that the cavity member substantially contacts the mucosal surface of the paranasal sinus after expansion. - View Dependent Claims (99, 100, 101, 102)
-
- 103. A device configured to deliver an active agent and to prevent lateralization of the middle turbinate.
- 105. A device configured to deliver an active agent and to prevent tissue adhesions in the area proximate a sinus cavity or proximate an area or an excised sinus cavity.
- 107. A device for treating a paranasal sinus condition comprising an active agent dispersed within a biodegradable polymer matrix, wherein the device comprises a cavity member, an ostial member, and optionally a nasal portion, and exhibits an in vivo cumulative release profile in which a therapeutically effective amount of said active agent is maintained in a sinus tissue for at least about 35 days after implantation of the device.
Specification